CDK4 and head and neck squamous cell carcinoma: The combination of mTOR inhibitors with abemaciclib enhances its anticancer effect.361 PD-0332991 is a specific inhibitor of CDK4/6 that has demonstrated potent anticancer effects in HNSCC.